"Strong reasons make strong actions"--The antiviral efficacy of NS3/4A protease inhibitors

Hepatology. 2005 Mar;41(3):671-4. doi: 10.1002/hep.20610.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Carbamates / adverse effects
  • Carbamates / pharmacology
  • Carbamates / therapeutic use*
  • Double-Blind Method
  • Drug Resistance, Viral
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Macrocyclic Compounds / adverse effects
  • Macrocyclic Compounds / pharmacology
  • Macrocyclic Compounds / therapeutic use*
  • Quinolines / adverse effects
  • Quinolines / pharmacology
  • Quinolines / therapeutic use*
  • RNA, Viral / analysis
  • Serine Proteinase Inhibitors / therapeutic use*
  • Thiazoles / adverse effects
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use*
  • Viral Nonstructural Proteins / antagonists & inhibitors*

Substances

  • Antiviral Agents
  • BILN 2061
  • Carbamates
  • Macrocyclic Compounds
  • NS3 protein, hepatitis C virus
  • NS4 protein, hepatitis C virus
  • Quinolines
  • RNA, Viral
  • Serine Proteinase Inhibitors
  • Thiazoles
  • Viral Nonstructural Proteins